The Indian Journal of Chest Diseases and Allied Sciences

Register      Login

VOLUME 65 , ISSUE 1 ( January-March, 2023 ) > List of Articles

ORIGINAL RESEARCH

Screening Parameters for COPD-OSA Overlap Syndrome in COPD Patients: Indian Perspective

Ishani Deshmukh, Dipti Gothi, Sameer Vaidya, Mahismita Patro

Keywords : Body mass index, Chronic obstructive pulmonary disease, Forced expiratory volume at 1 second, Obstructive sleep apnea, Snoring

Citation Information : Deshmukh I, Gothi D, Vaidya S, Patro M. Screening Parameters for COPD-OSA Overlap Syndrome in COPD Patients: Indian Perspective. Indian J Chest Dis Allied Sci 2023; 65 (1):6-11.

DOI: 10.5005/jp-journals-11007-0058

License: CC BY-NC 4.0

Published Online: 29-06-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Abstract

Introduction: As Indian patients have different predisposing morphological characteristics, we undertook this study to evaluate the clinical profile of overlap syndrome and compare them with COPD patients to find out the screening tools for obstructive sleep apnea (OSA) in Indian chronic obstructive pulmonary disease (COPD) patients. Aims and objectives: • To study the clinical profile of patients with overlap syndrome. • To compare them with COPD patients. • To develop screening tools for overlap syndrome in COPD. Materials and methods: A prospective case-control study was carried out in a tertiary care center. Overnight pulse oximetry was carried out for all COPD patients. Those having snoring or saw-tooth pattern on overnight oximetry were subjected to level 1 polysomnography. About 30 patients of overlap syndrome were compared with 65 COPD patients. Results: The mean age in overlap syndrome group (56.9 ± 6.86 years) was significantly lower (p < 0.01). The daytime PaO2 and lowest nocturnal saturation were significantly lower in overlap group. PaCO2 and forced expiratory volume at 1 second (FEV1) were significantly higher. For diagnosing overlap syndrome, the positive and the negative predictive values of snoring were 84.42 and 100%; of body mass index (BMI) ≥25 kg/m2 were 86.67 and 98.88%; and of excessive daytime sleepiness were 37.57 and 97.86%, respectively. Conclusion: Absence of snoring and BMI <25 kg/m2 virtually rules out overlap syndrome. The EDS has a high false-positive rate for predicting OSA. Patients having overlap syndrome have poor daytime and nocturnal oxygenation despite good lung functions.


HTML PDF Share
  1. Flenley DC. Sleep in chronic obstructive lung disease. Clin Chest Med 1985;6:651–661. PMID: 2935359.
  2. Krachman SL, Tiwari R, Vega ME, et al. Effect of emphysema severity on the apnea-hypopnea index in smokers with obstructive sleep apnea. Ann Am Thorac Soc 2016;13(7):1129–1135. DOI: 10.1513/AnnalsATS.201511-765OC.
  3. Kim V, Han MK, Vance GB, et al. The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study. Chest 2011;140(3):626–633. DOI: 10.1378/chest.10-2948.
  4. Owens RL, Malhotra A. Sleep-disordered breathing and COPD: the overlap syndrome. Respir Care 2010;55(10):1333–1346. PMID: 20875160.
  5. Singh S, Kaur H, Sigh S, et al. The overlap syndrome. Cureus 2018;10(10):e3453. DOI: 10.7759/cureus.3453.
  6. Chaouat A, Weitzenblum E, Krieger J, et al. Association of chronic obstructive pulmonary disease and sleep apnea syndrome. Am J Respir Crit Care Med 1995;151(1):82–86. DOI: 10.1164/ajrccm.151.1.7812577.
  7. Shepard JW, Garrison MW, Grither DA, et al. Relationship of ventricular ectopy to nocturnal oxygen desaturation in patients with chronic obstructive pulmonary disease. Am JMed 1985;78(1):28–34. DOI: 10.1016/0002-9343(85)90457-7.
  8. Bradley TD, Rutherford R, Grossman RF, et al. Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis 1985;131(6):835-839. DOI: 10.1164/arrd.1985.131.6.835.
  9. Sanjay S. COPD-OSA “The Overlap syndrome”. Indian J Appl Res 2018;8(7):1–3. DOI: 10.36106/ijar.
  10. Grover H, Janmeja AK, Aggarwal D. Obstructive sleep apnea in chronic obstructive pulmonary disease – overlap syndrome in a tertiary care center in Northern India. Chest 2015;148(4):1048A. DOI: 10.1378/chest.2263675.
  11. Halkanche GV, Mhaisekar DG. Study of correlation between obstructive sleep apnea and obstructive airway disease. MedPulse Int Med J 2017;4(2):217–221. DOI: 18 February 2017.
  12. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management, and prevention of COPD, 2018. Accessed on 21 Nov, 2019. Available from: http://goldcopd.org.
  13. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry “ATS/ERS task force: standardisation of lung function testing.” Eur Respir J 2005;26(2): 319–338. DOI: 10.1183/09031936.05.00034805.
  14. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350(10):1005–1012. DOI: 10.1056/NEJMoa021322.
  15. Netzer N, Eliasson A, Netzer C, et al. Overnight pulse oximetry for sleep-disordered breathing in adults. Chest 2001;120(2):625–633. DOI: 10.1378/chest.120.2.625.
  16. Berry RB, Budhiraja R, Gottlieb DJ, et al. Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the scoring of sleep and associated events. deliberations of the sleep apnea definitions task force of the American Academy of Sleep Medicine. J Clin Sleep Med 2012;8(5):597–619. DOI: 10.5664/jcsm.2172.
  17. Johns MW. A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep 1991;14:540–545. DOI: 10.1093/sleep/14.6.540.
  18. Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med. 2013;35(2):121–126. DOI: 10.4103/0253-7176.116232.
  19. McNicholas WT. Chronic obstructive pulmonary disease and obstructive sleep apnoea—the overlap syndrome. J Thorac Dis 2016;8(2):236–242. DOI: 10.3978/j.issn.2072-1439.2016.01.52.
  20. Schreiber A, Cemmi F, Ambrosino N, et al. Prevalence and predictors of obstructive sleep apnea in patients with chronic obstructive pulmonary disease undergoing inpatient pulmonary rehabilitation. COPD 2018;15(3):265–270. DOI: 10.1080/15412555.2018.1500533.
  21. Chung F, Abdullah HR, Liao P. STOP-Bang questionnaire: a practical approach to screen for obstructive sleep apnea. Chest 2016;149(3):631–638. DOI: 10.1378/chest.15-0903.
  22. Chung F, Yegneswaran B, Liao P, et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology 2008;108(5):812–821. DOI: 10.1097/ALN.0b013e31816d83e4.
  23. Steveling EH, Christian F, Clarenbach CF, et al. Predictors of the overlap syndrome and its association with comorbidities in patients with chronic obstructive pulmonary disease. Respiration 2014;88(6):451–457. DOI: 10.1159/000368615.
  24. Pan WH, Yeh WT. How to define obesity? Evidence-based multiple action points for public awareness, screening, and treatment: an extension of Asian-Pacific recommendations. Asia Pac J Clin Nutr 2008;17(3):370–374. PMID: 18818155.
  25. Lim JU, Lee JH, Kim JS, et al. Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients Int J COPD 2017:12 2465–2475. DOI: 10.2147/COPD.S141295.
  26. Yu X, Fujimoto K, Urushibata K, et al. Cephalometric analysis in obese and nonobese patients with obstructive sleep apnea syndrome. Chest 2003;124(1):212–218. DOI: 10.1378/chest.124.1.212.
  27. Akashiba T, Kawahara S, Kosaka N, et al. Determinants of chronic hypercapnia in Japanese men with obstructive sleep apnea syndrome. Chest 2002;121(2):415–421. DOI: 10.1378/chest.121.2.415.
  28. Patro M, Gothi D, Ojha UC, et al. Predictors of obesity hypoventilation syndrome among patients with sleep-disordered breathing in India. Lung India 2019;36(6):499–505. DOI: 10.4103/lungindia.lungindia_61_19.
  29. Sanders MH, Newman AB, Haggerty CL, et al. Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease. Am J Respir Crit Care Med 2003;167(1):7–14. DOI: 10.1164/rccm.2203046.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.